Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic (semaglutide) to reduce certain risks ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Research shows that GLP-1 receptor agonists like Ozempic can help you drop weight, manage diabetes, and even potentially ...

Nobody designed GLP-1s to reduce Alzheimer’s disease.” Nigel Greig, who heads drug design and development within the National ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and ...

A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.

A recent study linked semaglutide to lower risks of Alzheimer's disease in people with type 2 diabetes. But it's too early to say that Ozempic can help Alzheimer’s, Castro-Tié tells PEOPLE. “We need ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...